SCHEMBL25959652

SCHEMBL25959652

CS(=O)(=O)Cn1nc(C(=O)Nc2ccc(F)cc2F)c(Br)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.53
NPC1 O15118 1/20 0.53
TSHR P16473 1/20 0.47
LMNA P02545 2/20 0.47
GAA P10253 1/20 0.45
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
TP53 P04637 2/20 0.43
ALOX15 P16050 1/20 0.43
ALDH1A1 P00352 2/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPK1 P28482 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25959637 0.92 ALOX15 (0.53) RAB9ANPC1LMNAALOX15
SCHEMBL25958272 0.91 NPC1 (0.42) RAB9ANPC1TSHRLMNATP53
SCHEMBL25959641 0.89 LMNA (0.51) RAB9ANPC1TSHRLMNAGAA
SCHEMBL25959681 0.89 RAB9A (0.49) RAB9ANPC1TSHRLMNAGAA
SCHEMBL25959684 0.89 RAB9A (0.54) RAB9ANPC1TSHRLMNAGAA
SCHEMBL22257175 0.84 RAB9A (0.53) RAB9ANPC1TSHRLMNAGAA
SCHEMBL25959682 0.83 ALOX15 (0.53) RAB9ANPC1LMNATP53ALOX15
SCHEMBL25959640 0.83 NPC1 (0.43) RAB9ANPC1KDM4ERXFP1ALOX15
SCHEMBL25958268 0.82 MAPT (0.46) RAB9ANPC1TSHRLMNATP53
SCHEMBL25959674 0.81 TSHR (0.49) RAB9ANPC1TSHRLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME EMPIRICO INC. 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248752-A1 PRODRUGS OF ALOX-15 INHIBITORS AND METHODS OF USING THE SAME ALOX15, ALOX5, ALOX15B RAB9A 4106/4885NPC1 2279/4885TSHR 4118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.